Mehmet Ugur

Mehmet Ugur

Auto-generated profile, based on publicly available information

Mehmet Ugur

Ankara University

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Diabetes
Verified
Journal Article
Open access
PDF file
NYNazmi Yaras
Nazmi Yaras
MUMehmet Ugur
Mehmet Ugur
SOSemir Ozdemir
Semir Ozdemir
HGHakan Gurdal
Hakan Gurdal
NPNuhan Purali
Nuhan Purali
BTBelma Turan
Belma Turan
The defects identified in the mechanical activity of the hearts from type 1 diabetic animals include alteration of Ca2+ signaling via changes in critical processes that regulate intracellular Ca2+ concentration. These defects result partially from a dysfunction of cardiac ryanodine receptor calcium release channel (RyR2). The present study was designed to determine whether the properties of the Ca2+ sparks might provide insight into the role of RyR2 in the altered Ca2+ signaling in cardiomyocytes from diabetic animals when they were analyzed together with Ca2+ transients. Basal Ca2+ level as well as Ca2+-spark frequency of cardiomyoctes isolated from 5-week streptozotocin (STZ)-induced diabetic rats significantly increased with respect to aged-matched control rats. Ca2+ transients exhibited significantly reduced amplitude and prolonged time courses as well as depressed Ca2+ loading of sarcoplasmic reticulum in diabetic rats. Spatio-temporal properties of the Ca2+ sparks in cardiomyocytes isolated from diabetic rats were also significantly altered to being almost parallel to the changes of Ca2+ transients. In addition, RyR2 from diabetic rat hearts were hyperphosphorylated and protein levels of both RyR2 and FKBP12.6 depleted. These data show that STZ-induced diabetic rat hearts exhibit altered local Ca2+ signaling with increased basal Ca2+ level.

14 July 1997 in FEBS Letters
Verified
Journal Article
Closed access
SPSteven Petrou
Steven Petrou
MUMehmet Ugur
Mehmet Ugur
RDRobert M Drummond
Robert M Drummond
JSJoshua J Singer
Joshua J Singer
JWJohn V. Walsh
John V. Walsh

1 March 1998 in Molecular Pharmacology
Verified
Journal Article
Closed access
SMSankar Mitra
Sankar Mitra
MUMehmet Ugur
Mehmet Ugur
OUOzlem Ugur
Ozlem Ugur
HGH. Maurice Goodman
H. Maurice Goodman
JMJohn R. McCullough
John R. McCullough
HYHiroshi Yamaguchi
Hiroshi Yamaguchi
Racemic albuterol has been one of the most widely used β2-adrenoceptor agonists for the relief of the symptoms of asthma, yet the use of β2 agonists has been known to induce bronchial hyperresponsiveness. To probe a possible role of theS-enantiomer for hyperresponsiveness, we determined the effects of (S)-albuterol on intracellular Ca2+ concentration ([Ca2+]i) in dissociated bovine tracheal smooth muscle cells. Both (S)-and (R,S)-albuterol increased [Ca2+]i at concentrations of >10 pm and 1 nm, respectively, with a maximal response by 150 and 100 nm, respectively. (S)-Albuterol (1 and 10 μm) induced Ca2+ oscillations, reaching 1–2 μm[Ca2+]i. This response is in a stark contrast to that of (R)-albuterol, which decreased [Ca2+]i. The increase in [Ca2+]i was blocked by 100 nmatropine or 500 nm4-diphenylacetoxy-N-methylpiperidine but was insensitive to the β2 antagonist ICI 118,551 (10 μm). (S)-Albuterol (10 μm) increased inositol-1,4,5-trisphosphate levels by 213 ± 34.4% (p < 0.05, four experiments) in cells exposed for 30 sec. The sustained phase of the Ca2+ increase was absent in Ca2+-free solution, suggesting that Ca2+ influx was responsible for the sustained Ca2+ response. The results also suggest that (S)-albuterol may cross-react with muscarinic receptors. As a Ca2+ agonist in airway smooth muscle, (S)-albuterol may have profound clinical implications because 50% of prescribed racemic albuterol is composed of (S)-albuterol.

1 June 2004 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
MAMurat Ayaz
Murat Ayaz
SOSemir Ozdemir
Semir Ozdemir
MUMehmet Ugur
Mehmet Ugur
GVGuy Vassort
Guy Vassort
BTBelma Turan
Belma Turan

1 December 2009 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
SCSerife Cankurtaran-Sayar
Serife Cankurtaran-Sayar
KSKemal Sayar
Kemal Sayar
MUMehmet Ugur
Mehmet Ugur
P2X7 receptor has gained an increasing importance as a drug target. One important response to P2X7 receptor stimulation is the uptake of large molecular weight tracers into cells. However, mechanism for this response is not understood clearly, but it is generally believed that a nonselective large pore protein forms this P2X7 receptor-activated permeability pathway. We examined human embryonic kidney (HEK) 293 cells transfected with rat P2X7 receptors (HEK-rP2X7) and a macrophage derived cell line, RAW 264.7, that expresses an endogenous P2X7 receptor. We used confocal microscopy to investigate uptake of different types of dyes into these cells after ATP application. Stimulation of P2X7 receptors in HEK-rP2X7 cells activated two different dye uptake pathways. The first was permeable to the cationic fluorescent dyes YO-PRO-1 and TO-TO-1 but not to the anionic dyes lucifer yellow and calcein and did not require intracellular Ca2+ concentration ([Ca2+]i) increase to be activated. The second pathway permeated only lucifer yellow and was completely dependent on [Ca2+]i for activation. In RAW 264.7 cells, P2X7 receptor stimulation activated uptake of ethidium, YO-PRO-1, TO-TO-1, lucifer yellow, and calcein. Again, two different permeation pathways were discerned in RAW 264.7 cells: one permeated only ethidium and the other one, only lucifer yellow. We did observed no clear [Ca2+]i dependence for these permeation pathways. Our results demonstrate that instead of a single nonselective pore, P2X7 receptor seems to activate at least two permeation pathways, one for cationic and one for anionic dyes with different activation properties.

9 November 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
ETErkan Tuncay
Erkan Tuncay
ATAyca Bilginoglu Topcu
Ayca Bilginoglu Topcu
NSNazli N. Sozmen
Nazli N. Sozmen
EZEsma N. Zeydanli
Esma N. Zeydanli
MUMehmet Ugur
Mehmet Ugur
BTBelma Turan
Belma Turan
Zinc exists in biological systems as bound and histochemically reactive free Zn2+. It is an essential structural constituent of many proteins, including enzymes from cellular signalling pathways, in which it functions as a signalling molecule. In cardiomyocytes at rest, Zn2+ concentration is in the nanomolar range. Very little is known about precise mechanisms controlling the intracellular distribution of Zn2+ and its variations during cardiac function. Live-cell detection of intracellular Zn2+ has become feasible through the recent development of Zn2+-sensitive and –selective fluorophores able to distinguish Zn2+ from Ca2+. Here, in freshly isolated rat cardiomyocytes, we investigated the rapid changes in Zn2+ homeostasis using the Zn2+-specific fluorescent dye, FluoZin-3, in comparison to Ca2+-dependent fluo-3 fluorescence. Zn2+ sparks and Zn2+ transients, in quiescent and electrically stimulated cardiomyocytes, respectively, were visualized in a similar manner to known rapid Ca2+ changes. Both Zn2+ sparks and Zn2+ transients required Ca2+ entry. Inhibiting the sarcoplasmic reticulum Ca2+ release or increasing the Ca2+ load in a low-Na+ solution suppressed or increased Zn2+ movements, respectively. Mitochondrial inhibitors slightly reduced both Zn2+ sparks and Zn2+ transients. Oxidation by H2O2 facilitated and acidic pH inhibited the Ca2+-dependent Zn2+ release. It is proposed that Zn2+ release during the cardiac cycle results mostly from intracellular free Ca2+ increase, triggering production of reactive oxygen species that induce changes in metal-binding properties of metallothioneins and other redox-active proteins, aside from ionic exchange on these proteins.